B. Zane Atkins, MD, Scott C. Silvestry, MD, Ravi N. Samy, MD, Ashish S

Slides:



Advertisements
Similar presentations
The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.
Advertisements

Bidirectional cavopulmonary shunt with right ventricular outflow patency: The impact of pulsatility on pulmonary endothelial function  Shunji Kurotobi,
Manuel J. Antunes, MD, PhD, DSc 
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat  Ryuzo Bessho, MD, PhD, David J. Chambers,
Reduction of systolic and diastolic dysfunction by retrograde coronary sinus perfusion during off-pump coronary surgery  Manuel Castellá, MD, Gerald D.
Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor  Michio Kawasuji, MD, Hiroshi Nagamine, MD, Masahiro Ikeda,
A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion.
Creating an ideal “off-test mode” for rotary left ventricular assist devices: Establishing a safe and appropriate weaning protocol after myocardial recovery 
EMPA-REG OUTCOME: The Cardiologist's Point of View
Results of Valve Replacement With Mechanical and Biological Prostheses in Chronic Renal Dialysis Patients  John C Lucke, Ravi N Samy, B.Zane Atkins, Scott.
Per Steinar Halvorsen, MD, Espen W
Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model  Glenn W. Laub, MD, S. Muralidharan, MD, Jerome.
Ultrasound, endoscopy, and the recurrent nerve
Building a bioartificial heart: A 3-song saga
Walter J. Scott, M.D., Bruce L. Gewertz, M.D. 
Intramyocardial Left Ventricle-to-Coronary Artery Stent: A Novel Approach for the Treatment of Coronary Artery Disease  Geng-Hua Yi, MD, Eva Maria Becker,
Akihiko Ohkado, MD, Hung Cao-Danh, PhD, K. Eric Sommers, MD, Pedro J
Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization 
Direct coronary artery perfusion from the left ventricle
Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump  Satoshi Kono, MDa, Kazunobu Nishimura, MD, PhDa, Takeshi Nishina,
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Effects of intracoronary calcium chloride on regional oxygen balance and mechanical function in normal and stunned myocardium in dogs  K.Y. Yoo, J.U.
Effects of cardioplegia on vascular function and the “no-reflow" phenomenon after ischemia and reperfusion: Studies in the isolated blood-perfused rat.
Effect of acutely increased left ventricular afterload on work output from the right ventricle in conscious dogs  Mohanraj K. Karunanithi, BE, MBiomedE,
Retrograde cardioplegia
LV-powered coronary sinus retroperfusion reduces infarct size in acutely ischemic pigs  Jeffrey S Martin, MD, John G Byrne, MD, Olivier Y Ghez, MD, Umer.
Protection of the kidney after temporary ischemia: Free radical scavengers  Kenneth Ouriel, M.D., Nicholas G. Smedira, M.D. *, John J. Ricotta, M.D.  Journal.
Physiologic Effects Of Extracellular Superoxide Dismutase Transgene Overexpression On Myocardial Function After Ischemia And Reperfusion Injury  Edward.
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange  Manuel Castellá, MDa, Gerald D. Buckberg, MDa,
Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial.
Support Your Specialty
Brian R. Weil et al. BTS 2017;2: Brief Myocardial Ischemia Produces Transient LV Dysfunction Consistent With Stunned Myocardium A 10-min total left.
Mohanraj K. Karunanithi, BE, MBiomedE, Michael P
Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts  Satoshi Yamashiro, MDa,b, Katsuhiko Noguchi,
Early effects of right ventricular volume overload on ventricular performance and β- adrenergic signaling  Ashish S. Shah, MD, B.Zane Atkins, MD, Jonathan.
Dysfunction induced by ischemia versus edema: Does edema matter?
Experimental study of intermittent crossclamping with fibrillation and myocardial protection: Reduced injury from shorter cumulative ischemia or intrinsic.
Ischemic preconditioning with opening of mitochondrial adenosine triphosphate– sensitive potassium channels or Na+/H+ exchange inhibition: Which is the.
REVERSAL OF IATROGENIC MYOCARDIAL EDEMA AND RELATED ABNORMALITIES OF DIASTOLIC PROPERTIES IN THE PIG LEFT VENTRICLE  David A. Dean, MDa*, Mehrdad M. Amirhamzeh,
David C. Stuesse, MDa, George D. Giraud, MD, PhDb, Angelo A
Navin K. Kapur, MD, Jenica Upshaw, MD, Michael S
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Right ventricular diastolic relaxation in conscious dog models of pressure overload, volume overload, and ischemia  Ares D. Pasipoularides, MD, PhD, Ming.
Left atrial pressure measurement in a rat is currently impossible due to size limitations of balloon occlusion catheter  Filip Konecny, MSc, DVM, PhD 
Insulin cardioplegia for elective coronary bypass surgery
Ischemic preconditioning does not acutely improve load-insensitive parameters of contractility in in vivo stunned porcine myocardium  M.Salik Jahania,
Protein kinase C isoform–dependent myocardial protection by ischemic preconditioning and potassium cardioplegia  Kejie Lu, MD*, Hajime Otani, MD, Tadashi.
Shunt right or left? Decision 2016
Adenosine-enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia  James D McCully, PhD, Masahisa Uematsu,
Relationship of hospital size, case volume, and cost for coronary artery bypass surgery: Analysis of 12,774 patients operated on in Massachusetts during.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Keep it short and sweet  Ian A. Makey, MD, Scott B. Johnson, MD 
Tai Ji: The law of inflammatory response
James E. Davies, MD, Stanley B. Digerness, PhD, Cheryl R
L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts  Michael T. Kronon, MD, Bradley.
Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin  Gerhard A. Kalweit, MDa, Jochen D. Schipke,
Early effects of hypothyroidism on the contractile function of the rat heart and its tolerance to hypothermic ischemia  Manuel Galiñanes, MD, PhD, Ryszard.
Therapeutic R2 resection for pleural mesothelioma
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Nitroglycerin as a nitric oxide donor accelerates lipid peroxidation but preserves ventricular function in a canine model of orthotopic heart transplantation 
Commentary: Just say NO
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: Insight into ischemia-induced reduction in endothelium-dependent.
Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product  Gabriel P. Lasala, MD, FACC, Jose.
Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic Heart  Jacob Gurevitch, Dimitri Pevni, Inna Frolkis, Menachem Matsa, Yosi.
Randy M. Stevens, MD, M. Salik Jahania, MD, Robert M
Effects of in vivo myocardial ischemia and reperfusion on interstitial nitric oxide metabolites  Randy M Stevens, MD, M.Salik Jahania, MD, Jennifer E.
Acquired aortopulmonary fistula in acute dissection
Presentation transcript:

Calcitonin gene–related peptide enhances the recovery of contractile function in stunned myocardium  B.Zane Atkins, MD, Scott C. Silvestry, MD, Ravi N. Samy, MD, Ashish S. Shah, MD, David C. Sabiston, MD, Donald D. Glower, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 119, Issue 6, Pages 1246-1254 (June 2000) DOI: 10.1067/mtc.2000.105457 Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Experimental preparation shows the pneumatic occluder secured around the LAD coronary artery (A), left atrial introducer catheter (B), intramyocardial ultrasonic dimension transducer pair in the ischemic (darkened area ) LAD coronary artery region (C), and ultrasonic dimension transducer pair in the LCX coronary artery distribution (D). Implanted pleural catheters and vena caval pneumatic occluders are not shown. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Representative raw data derived from the LAD coronary artery and the LCX myocardial regions are shown for one animal. Segment lengths and LV transmural pressure-segment length work loops in the respective distributions during control conditions, acute ischemia, and after 1.5, 3, 8, and 24 hours of reperfusion document the regional ischemia and gradual recovery within the LAD coronary artery region. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 Mean heart rate (A) and LV end-diastolic pressure (B) for placebo, CGRP, and nitroglycerin (NTG ) during control conditions, acute ischemia, and 1.5, 3, 8, and 24 hours of reperfusion. NS , Not significant. Mean ejection pressure (C) and end-diastolic segment length (D) for placebo, CGRP, and nitroglycerin (NTG ) during control conditions, acute ischemia, and 1.5, 3, 8, and 24 hours of reperfusion. NS , Not significant. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 PRWA data (n = 6; mean ± SD) from the ischemic LAD coronary artery region after CGRP or nitroglycerin (NTG ) infusion compared with placebo. After reversible myocardial ischemia, contractile performance (PRWA) was significantly enhanced by CGRP over all reperfusion (P = .01) and after 1.5 hours of reperfusion (P = .04). Conversely, nitroglycerin did not significantly alter PRWA compared with placebo. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 5 PRWA data (n = 6; mean ± SD) expressed as percent baseline from the ischemic LAD coronary artery region after CGRP or nitroglycerin (NTG ) infusion compared with placebo. After reversible myocardial ischemia, PRWA was significantly enhanced by CGRP over all reperfusion (P = .01) and at each time in reperfusion (P < .05). Nitroglycerin did not significantly affect PRWA compared with placebo. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 6 PRWA data (mean ± SD) in the ischemic LAD coronary artery region for all 8 animals that received CGRP infusion compared with placebo. After reversible ischemia, contractile performance (PRWA) was significantly enhanced by CGRP over all reperfusion (P = .005) and at each time in reperfusion (P < .05). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 7 PRWA data (mean ± SD) from the nonischemic LCX coronary artery region after CGRP infusion compared with placebo. PRWA was increased during CGRP infusion; however, PRWA for CGRP and placebo were similar during the remainder of recovery. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1246-1254DOI: (10.1067/mtc.2000.105457) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions